NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NHGRI E-140-1999-1-US-01 Novel Methods and Reagents for the Treatment of Ostheoarthritis US CIP 09/802,207 Expired
NIAID E-115-2001-2-US-01 MVA Expressing Modified HIV Envelope, Gag And Pol Genes US 60/274,434 Abandoned
NCI E-200-1998-0-US-02 Fitness Assay and Associated Methods US National Stage 09/720,276 7470506 Expired PDF
NCI E-035-1998-0-US-06 Pteridine Nucleotide Analogs US National Stage 09/786,666 6716971 Abandoned PDF
NIAID E-205-1998-0-US-03 Inhibitors of Amyloid Formation US National Stage 09/762,725 6632808 Abandoned PDF
NCI E-311-2000-0-US-01 Thymidylate Synthase Peptides That Bind To Thymidylate Synthase Messenger RNA US 60/274,107 Abandoned
NIAID E-115-2001-1-US-01 MVA Expressing Modified HIV Envelope, Gag And Pol Genes US 60/274,626 Abandoned
NCI E-289-1999-0-CA-04 1,8-Naphthalimide Imidazo[4,5,1-de] acridones with Anti-Tumor Activity CA National Stage 2402446 Abandoned
NCI E-289-1999-0-AU-03 1,8-Naphthalimide Imidazo[4,5,1-de] acridones with Anti-Tumor Activity AU National Stage 2001240054 Abandoned
NCI E-289-1999-0-GB-11 1,8-Naphthalimide Imidazo[4,5,1-de] Acridones with Anti-Tumor Activity GB EP 01914696.8 Abandoned
NCI E-289-1999-0-CH-10 1,8-Naphthalimide Imidazo[4,5,1-de] Acridones with Anti-Tumor Activity CH EP 01914696.8 Abandoned
NCI E-289-1999-0-DE-09 1,8-Naphthalimide Imidazo[4,5,1-de] Acridones with Anti-Tumor Activity DE EP 01914696.8 Abandoned
NCI E-289-1999-0-FR-08 1,8-Naphthalimide Imidazo[4,5,1-de] Acridones with Anti-Tumor Activity FR EP 01914696.8 Abandoned
NCI E-289-1999-0-EP-06 1,8-Naphthalimide Imidazo[4,5,1-de] Acridones with Anti-Tumor Activity EP National Stage 01914696.8 Abandoned
NIDDK E-006-1998-2-US-01 Methods And Compositions For Reducing Ischemic Injury Of The Heart By Aministering Adenosine Receptor Agonists And Antagonists US CIP 09/800,274 6586413 Expired PDF
NCI E-289-1999-0-PCT-02 1,8-Naphthalimide Imidazo[4,5,1-de] Acridones With Anti-Tumor Activity PCT PCT PCT/US01/07087 Expired
NCI E-289-1999-0-JP-05 1,8-Naphthalimide Imidazo[4,5,1-de] acridones with Anti-Tumor Activity JP National Stage 2001-565361 Abandoned
NCI E-312-2001-0-US-01 Nucleic Acids of The Human ABCC11 Gene, Vectors Containing Such Nucleic Acids And Uses Thereof US 60/272,757 Abandoned
NCI E-313-2001-0-US-01 Nucleic Acids of The Human ABCC12 Gene, Vector Containing Such Nucleic Acids And Uses Thereof US 60/272,759 Abandoned
NIAID E-232-2004-2-CA-04 DNA Expression Vectors and Methods of Use CA National Stage 2401974 Expired
NIAID E-232-2004-2-AU-03 DNA Expression Vectors and Methods of Use AU National Stage 2002211948 Abandoned
NIAID E-232-2004-2-CN-07 DNA Expression Vectors and Methods of Use CN National Stage 01818162.7 Expired
NIAID E-232-2004-2-PCT-02 DNA expression vectors and methods of use PCT PCT PCT/US2001/006795 Expired
NIAID E-232-2004-2-US-01 DNA Expression Vectors and Methods of Use US CIP 09/798,675 Abandoned
NIAID E-232-2004-2-EP-05 DNA Expression Vectors and Methods of Use EP National Stage 01981921.8 Expired
NIAID E-232-2004-2-IN-09 DNA expression vectors and methods of use IN National Stage IN/PCT/2002/01197 Expired
NIDDK E-109-2001-0-US-03 Methods for Improving the Function of Heterogolous Protein-Coupled Receptors US National Stage 09/786,033 7094593 Abandoned PDF
CC E-278-1999-0-PCT-02 Multiplex Hybridization System for the Identification of Pathogenic Mycobacterium and Method of Use PCT PCT PCT/US01/06731 Abandoned
NIDCR E-131-1999-0-PCT-02 Methods for Wound Treatment PCT PCT PCT/US01/06675 Abandoned
CC E-278-1999-0-EP-03 Multiplex Hybridization System For Identification Of Pathogenic Mycobacterium And Method Of Use EP National Stage 01913255.4 Abandoned
NCI E-331-2000-0-US-02 DNA Encoding a Growth Factor Specific for Epithelial Cells US REISSUE 09/795,702 Abandoned
NHLBI E-003-2000-0-PCT-02 Regulators of Type-1 Tumor Necrosis Factor Receptor and Other Cytokine Receptor Shedding PCT PCT PCT/US01/06464 Expired
NIEHS E-080-1994-0-US-03 DIAGNOSTIC METHODS AND GENE THERAPY USING REAGENTS DERIVED FROM THE HUMAN METASTASIS SUPPRESSOR GENE KAI1 US DIV 09/795,380 6756201 Abandoned PDF
NCI E-282-2000-0-US-01 Analogs of Thalidomide as Potential Angiogenesis Inhibitors US 60/271,941 Abandoned
NCI E-143-1998-0-US-04 Nucleic Acids Comprising a Post-Transcriptional Regulatory Elements (PRE) and Their Uses US National Stage 09/673,716 6919442 Abandoned PDF
NIA E-180-1992-0-US-12 TARGETING OF LIPOSOMES TO THE BLOOD-BRAIN BARRIER US CON 09/794,719 Abandoned
NCI E-077-2001-0-US-01 Enhanced Homologous Recombination Mediated By Lambda Recombination Protein US 60/271,632 Abandoned
NCI E-009-2000-0-CA-06 Anti-EGFRvIII scFvs with Improved Cytotoxicity and Yield, Immunotoxins Based Thereon, and Methods of Use Thereof CA National Stage 2400868 Abandoned
NCI E-009-2000-0-FR-26 Anti-EGFRvIII SCFVs With Improved Cytotoxicity and Yield Immunotoxins Based Thereon, and Methods of Use Thereof FR EP 01914471.6 Abandoned
NCI E-009-2000-0-DE-25 Anti-EGFRvIII SCFVs With Improved Cytotoxicity and Yield Immunotoxins Based Thereon, and Methods of Use Thereof DE EP 01914471.6 Abandoned
NCI E-009-2000-0-GB-27 Anti-EGFRvIII SCFVs With Improved Cytotoxicity and Yield Immunotoxins Based Thereon, and Methods of Use Thereof GB EP 01914471.6 Abandoned
NCI E-009-2000-0-EP-03 Anti-EGFRvIII SCFVs With Improved Cytotoxicity and Yield Immunotoxins Based Thereon, and Methods of Use Thereof EP National Stage 01914471.6 Expired
NCI E-009-2000-0-KR-10 Anti-EGFRvIII scFvs with Improved Cytotoxicity and Yield, Immunotoxins Based Thereon, and Methods of Use Thereof KR National Stage 10-2002-7011187 Abandoned
NCI E-009-2000-0-RU-08 Anti-EGFRvIII scFvs with Improved Cytotoxicity and Yield, Immunotoxins Based Thereon, and Methods of Use Thereof RU National Stage 2002125514 Abandoned
NCI E-009-2000-0-UA-19 Anti-EGFRvIII scFvs With Improved Cytotoxicity and Yield, Immunotoxin Based Thereon, and Methods of Use Thereof UA National Stage 2002086976M Abandoned
NCI E-009-2000-0-AU-05 Anti-EGFRvIII scFvs with Improved Cytotoxicity and Yield, Immunotoxins Based Thereon, and Methods of Use Thereof AU National Stage 2001239857 Abandoned
NCI E-009-2000-0-PCT-02 Anti-EGFRvIII scFvs With Improved Cytotoxicity and Yield, Immunotoxin Based Thereon, and Methods of Use Thereof PCT PCT PCT/US2001/005923 Expired
NIAID E-171-1986-1-US-06 PERTUSSIS TOXIN GENE: CLONING AND EXPRESSION OF PROTECTIVE ANTIGEN US CON 09/792,861 Abandoned
NCI E-009-2000-0-JP-04 Anti-EGFRvIII scFvs with Improved Cytotoxicity and Yield, Immunotoxins Based Thereon, and Methods of Use Thereof JP National Stage 2001-562705 Abandoned
NCI E-009-2000-0-BA-23 Anti-EGFRvIII scFvs With Improved Cytotoxicity and Yield, Immunotoxin Based Thereon, and Methods of Use Thereof BA National Stage BAP021207A Abandoned